|Effectiveness of antipsychotic drugs in patients with chronic schizophrenia|
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
|The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity|
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
|Persistent cannabis users show neuropsychological decline from childhood to midlife|
MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ...
Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012
|Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial|
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
|The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery|
RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour
Schizophrenia research 68 (2-3), 283-297, 2004
|Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment|
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
|Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria|
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
|The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis|
RSE Keefe, SG Silva, DO Perkins, JA Lieberman
Schizophrenia bulletin 25 (2), 201-222, 1999
|Antipsychotic drug effects on brain morphology in first-episode psychosis|
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
|Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment|
PD Harvey, RSE Keefe
American Journal of Psychiatry 158 (2), 176-184, 2001
|Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators; Effectiveness of antipsychotic drugs in patients with chronic schizophrenia|
N Engl J Med 353, 1209-1223, 2005
|The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization|
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
|Schizophrenia is a cognitive illness: time for a change in focus|
RS Kahn, RSE Keefe
JAMA psychiatry 70 (10), 1107-1112, 2013
|Barriers to employment for people with schizophrenia|
R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ...
American Journal of Psychiatry 163 (3), 411-417, 2006
|Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic|
TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ...
American Journal of Psychiatry 163 (4), 611-622, 2006
|A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia|
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
|A genome-wide investigation of SNPs and CNVs in schizophrenia|
AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ...
PLoS Genet 5 (2), e1000373, 2009
|Baseline neurocognitive deficits in the CATIE schizophrenia trial|
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
|Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study|
A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ...
American Journal of Psychiatry 167 (2), 160-169, 2010
|Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol|
JA Lieberman, G Tollefson, M Tohen, AI Green, RE Gur, R Kahn, ...
American Journal of Psychiatry 160 (8), 1396-1404, 2003